or Try an Advanced Search...

    Technical Analysis for SHPH - Shuttle Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    D 0.38 -5.24% -0.02
    SHPH closed down 2.07 percent on Thursday, April 18, 2024, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SHPH trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish -5.33%
    NR7 Range Contraction -5.33%
    Inside Day Range Contraction -5.33%
    Gapped Down Weakness -5.33%
    Lower Bollinger Band Touch Weakness -5.33%
    50 DMA Support Bullish -7.29%
    Hammer Candlestick Bullish -7.29%
    Lower Bollinger Band Touch Weakness -7.29%
    50 DMA Support Bullish -9.52%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -9.52%
    Older End-of-Day Signals for SHPH ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    Down 5% about 2 hours ago
    Down 3% about 2 hours ago
    Fell Below Lower Bollinger Band about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SHPH Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Cancer Radiation Radiation Therapy Sarcoma Brain Tumor Soft Tissue Sarcoma Liver Cancer

    Is SHPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 5 Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
    Apr 3 Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
    Apr 3 Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
    Mar 22 Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
    Mar 5 Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
    Mar 5 Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
    Feb 13 Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
    Jan 23 Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
    Jan 19 Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Jan 8 Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    See more SHPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.75
    52 Week Low 0.35
    Average Volume 56,804
    200-Day Moving Average 0.57
    50-Day Moving Average 0.41
    20-Day Moving Average 0.42
    10-Day Moving Average 0.41
    Average True Range 0.03
    RSI (14) 44.75
    ADX 12.7
    +DI 11.24
    -DI 12.41
    Chandelier Exit (Long, 3 ATRs) 0.38
    Chandelier Exit (Short, 3 ATRs) 0.48
    Upper Bollinger Bands 0.45
    Lower Bollinger Band 0.39
    Percent B (%b) 0.13
    BandWidth 12.95
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram -0.003
    Fundamentals Value
    Market Cap 6.42 Million
    Num Shares 16 Million
    EPS -0.40
    Price-to-Earnings (P/E) Ratio -1.00
    Price-to-Sales 0.00
    Price-to-Book 1.08
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.43
    Resistance 3 (R3) 0.43 0.42 0.43
    Resistance 2 (R2) 0.42 0.41 0.42 0.42
    Resistance 1 (R1) 0.41 0.41 0.42 0.41 0.42
    Pivot Point 0.40 0.40 0.40 0.40 0.40
    Support 1 (S1) 0.39 0.39 0.40 0.39 0.38
    Support 2 (S2) 0.38 0.39 0.38 0.38
    Support 3 (S3) 0.37 0.38 0.38
    Support 4 (S4) 0.37